ALL STARTUPS
![Background](https://www.hub71.com/storage/media/19932/conversions/Avesta_image_png_ghNJQQWj-converted-webp.webp?v=1793174817" width="2232" height="1488" srcset="https://www.hub71.com/storage/media/19932/responsive-images/Avesta_image_png_ghNJQQWj___converted-webp_2232_1488.webp 2232w, https://www.hub71.com/storage/media/19932/responsive-images/Avesta_image_png_ghNJQQWj___converted-webp_1867_1245.webp 1867w, https://www.hub71.com/storage/media/19932/responsive-images/Avesta_image_png_ghNJQQWj___converted-webp_1562_1041.webp 1562w, https://www.hub71.com/storage/media/19932/responsive-images/Avesta_image_png_ghNJQQWj___converted-webp_1307_871.webp 1307w, https://www.hub71.com/storage/media/19932/responsive-images/Avesta_image_png_ghNJQQWj___converted-webp_1093_729.webp 1093w, https://www.hub71.com/storage/media/19932/responsive-images/Avesta_image_png_ghNJQQWj___converted-webp_915_610.webp 915w, https://www.hub71.com/storage/media/19932/responsive-images/Avesta_image_png_ghNJQQWj___converted-webp_765_510.webp 765w, https://www.hub71.com/storage/media/19932/responsive-images/Avesta_image_png_ghNJQQWj___converted-webp_640_427.webp 640w, https://www.hub71.com/storage/media/19932/responsive-images/Avesta_image_png_ghNJQQWj___converted-webp_535_357.webp 535w, https://www.hub71.com/storage/media/19932/responsive-images/Avesta_image_png_ghNJQQWj___converted-webp_448_299.webp 448w, https://www.hub71.com/storage/media/19932/responsive-images/Avesta_image_png_ghNJQQWj___converted-webp_375_250.webp 375w, https://www.hub71.com/storage/media/19932/responsive-images/Avesta_image_png_ghNJQQWj___converted-webp_313_209.webp 313w, https://www.hub71.com/storage/media/19932/responsive-images/Avesta_image_png_ghNJQQWj___converted-webp_262_175.webp 262w, https://www.hub71.com/storage/media/19932/responsive-images/Avesta_image_png_ghNJQQWj___converted-webp_219_146.webp 219w, https://www.hub71.com/storage/media/19932/responsive-images/Avesta_image_png_ghNJQQWj___converted-webp_183_122.webp 183w, https://www.hub71.com/storage/media/19932/responsive-images/Avesta_image_png_ghNJQQWj___converted-webp_153_102.webp 153w, https://www.hub71.com/storage/media/19932/responsive-images/Avesta_image_png_ghNJQQWj___converted-webp_128_85.webp 128w)
Avesta 76 Therapeutics
Avesta 76 Therapeutics is developing medicines targeting how cancer survives, while using AI to uncover therapeutic opportunities from proprietary biology across oncology, metabolic disease, and longevity.
![Logo](https://www.hub71.com/storage/media/19931/conversions/Avesta_png_46yre7FK-converted-webp.webp?v=1793174782" width="1476" height="425" srcset="https://www.hub71.com/storage/media/19931/responsive-images/Avesta_png_46yre7FK___converted-webp_1476_425.webp 1476w)
SECTOR:
Health and Life Sciences
FOUNDED IN:
United States of America
STAGE:
Seed
PROGRAMME ENROLLED IN:
Life Sciences